Receipt of cardiac screening does not influence 1-year post–cerebrovascular event mortality
暂无分享,去创建一个
J. Concato | D. Bravata | L. Williams | M. Reeves | Zhangsheng Yu | L. Myers | E. Cheng | G. Arling | J. Sico | A. Zillich | J. Ferguson | F. Baye | F. Jadbabaie | L. Williams | Jason J. Sico
[1] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[2] A. Bagai,et al. Population-Based Study on Patterns of Cardiac Stress Testing After Percutaneous Coronary Intervention , 2017, Circulation. Cardiovascular quality and outcomes.
[3] J. Carroll,et al. Letter by Saver et al regarding article, "Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association". , 2015, Stroke.
[4] D. Bravata,et al. Abstract 121: Vascular Risk Factor Control in the Year After Ischemic Stroke Versus Myocardial Infarction , 2015 .
[5] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[6] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.
[7] B. Ovbiagele,et al. Utility of Framingham Coronary Heart Disease Risk Score for Predicting Cardiac Risk After Stroke , 2012, Stroke.
[8] Emmanuel Touzé,et al. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. , 2012, Stroke.
[9] John Spertus,et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.
[10] D. Bravata,et al. Using Administrative Databases to Calculate Framingham Scores Within a Large Health Care Organization , 2011, Stroke.
[11] D. Liebeskind,et al. Prognostic value of Framingham Cardiovascular Risk Score in hospitalized stroke patients. , 2011, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[12] P. Touboul,et al. Prevalence of Coronary Atherosclerosis in Patients With Cerebral Infarction , 2011, Stroke.
[13] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.
[14] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[15] D. Liebeskind,et al. Optimizing Screening and Management of Asymptomatic Coronary Artery Disease in Patients With Stroke and Patients With Transient Ischemic Attack , 2009, Stroke.
[16] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[17] D. Wennberg,et al. Differences in cardiac stress testing by sex and race among Medicare beneficiaries. , 2007, American heart journal.
[18] H. Diener,et al. Predictors of Early Cardiac Morbidity and Mortality After Ischemic Stroke , 2007, Stroke.
[19] J. Concato,et al. Readmission and Death After Hospitalization for Acute Ischemic Stroke: 5-Year Follow-Up in the Medicare Population , 2007, Stroke.
[20] C. Maynard,et al. Accuracy and completeness of mortality data in the Department of Veterans Affairs , 2006, Population health metrics.
[21] G. Chatellier,et al. Risk of Myocardial Infarction and Vascular Death After Transient Ischemic Attack and Ischemic Stroke: A Systematic Review and Meta-Analysis , 2005, Stroke.
[22] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.
[23] E. Antman,et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.
[24] J. Alpert,et al. Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. , 2003, Circulation.
[25] Joseph S Alpert,et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.
[26] E. Antman,et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Journal of the American College of Cardiology.
[27] K. Furie,et al. Cardiac evaluation of stroke patients , 1998, Neurology.
[28] R. Poole,et al. Frequency and severity of asymptomatic coronary disease in patients with different causes of stroke. , 1997, Stroke.
[29] D. Berman,et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. , 1996, Circulation.
[30] J. Concato,et al. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. , 1995, Journal of clinical epidemiology.
[31] P Peduzzi,et al. Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy. , 1995, Journal of clinical epidemiology.
[32] G Germano,et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. , 1995, Journal of the American College of Cardiology.
[33] J. Whittle,et al. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. , 1993, The New England journal of medicine.
[34] A. Epstein,et al. Racial inequalities in the use of procedures for patients with ischemic heart disease in Massachusetts. , 1989, JAMA.
[35] Jeffrey L. Anderson,et al. ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults , 2010 .
[36] A. U. Rickel,et al. Guidelines for Prevention, I , 1998 .
[37] F. Zacharias. Beta blockers in hypertension. , 1973, Bruxelles medical.